Bayer begins the process of developing itself into a life sciences company. From Jan. 1, 2016, the company’s business will be managed by three divisions: Pharmaceuticals, Consumer Health and Crop Science.
“In recent years, Bayer has continued developing its portfolio with a significant focus on the life sciences. The company’s very strong position at this time enables it to concentrate exclusively on these businesses. The logical conclusion of this is greater integration of the organization,” says Werner Wenning, chairman of the supervisory board of Bayer AG.
As part of the reorganization, Bayer CropScience subgroup will become the Crop Science Division.
More information is available here: http://www.press.bayer.com/baynews/baynews.nsf/ID/9FA5272A6CB89107C1257EC4003D33AA
